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Abstract
Objective: Depression is an important health issue in cancer patients. People use different coping strat-
egies and health locus of control to manage stressful situations, which relate to different risks of de-
pression. Coping strategies and health locus of control can be changed by cognitive behavioral
interventions.
Methods: In a cohort study, we investigated differences in coping strategy and health locus of con-
trol in older (≥70 years) and middle-aged (50–69 years) cancer patients, and older patients without
cancer (≥70 years), and their association with presence of depression. We also investigated how these
factors interact. We used the short version of the Utrecht Coping List, the Multidimensional Health
Locus of Control scale, and the 15-item Geriatric Depression Scale.
Results: Data were available from 1317 participants. Overall prevalence of depression was 12%.
Older cancer patients tended to use an avoiding coping strategy more frequently than middle-aged
cancer patients. This was associated with higher risk of depression. Older cancer patients less often
used an active coping strategy, in comparison with middle-aged cancer patients, which was associated
with a lower risk of depression. Especially in women using a seeking social support strategy, there was
a lower risk of depression. Overall, the internal health locus of control was associated with higher and
the external ‘powerful others’ locus with lower risk of depression.
Conclusions: Older cancer patients strongly differ from middle-aged cancer patients, in particu-
lar with respect to coping. Interventions to prevent or alleviate depression should incorporate these
differences.
Copyright © 2015 John Wiley & Sons, Ltd.
Background
According to the Dutch Cancer Registration, the incidence
of cancer will increase from 74,000 new cases in 2002 up
to 101,000 new cases in 2015. At the time of diagnosis,
about two-thirds of all patients is older than 60 years
[1,2]. The prevalence of depression in older cancer pa-
tients is estimated between 17% and 25% [3]. Depressed
cancer patients have a poorer quality of life, increased
pain, less physical activity and decreased social func-
tioning, in comparison with nondepressed patients [4].
Hence, depression is an important health issue in cancer
patients.
Coping can be deﬁned as thoughts and behaviors that
people use to manage internal and external demands that
are appraised as stressful [5]. A person may use different
coping strategies over time, and the effectivity of a certain
strategy depends on the situation. Several studies found
that cancer patients using active, problem-focused coping
strategies were healthier both psychologically and physi-
cally [6,7]. Cancer patients using an avoiding coping strat-
egy experienced more depressive symptoms and worse
physical health, although, not all studies conﬁrm this [7–
9]. Cognitive–behavioral therapy proved to change coping
strategies of cancer patients [10].
Another important predictor of depression could be
health locus of control. Some people believe that their
health status is controlled by themselves, they believe that
they stay or become healthy as a result of their own behav-
ior (called internal health locus of control) [11]. Others be-
lieve that their health status is controlled by powerful
others or chance, so factors that determine their health
are ones over which they have little control (called exter-
nal and chance health locus of control, respectively)
[11]. Perceived control might decline after cancer diagno-
sis and during the process of aging [12,13]. Still, the rela-
tionship between internal control and psychological
adjustment to cancer remains largely unknown [8]. What
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we do know is that to a large extent, perception of control
can be taught [14].
Until now, associations between depression, coping
strategy, and health locus of control among older cancer
patients with different types of cancer are hardly studied.
If there are differences between younger and older cancer
patients and people without cancer, it may be possible to
identify these particular groups. Thus, more knowledge
in this ﬁeld may have therapeutic implications, because
it is possible to change both health locus of control and
coping strategy, and new interventions could reduce
depression among older cancer patients [10,14,15]. The
objective of this study is to investigate the association
between coping strategy, health locus of control and
depression in older (≥70 years) cancer patients. The
impact of age and cancer will be evaluated by comparing
the results of middle-aged (50–69 years) cancer patients
and older patients (≥70 years) without cancer. Our second-
ary aim is to investigate how these factors interact.
Methods
Study design
This study comprises cross-sectional analyses using base-
line data of all the patients included in the KLIMOP-study
(Dutch acronym for project on older cancer patients in
Belgium and the Netherlands) between June 2010 and
December 2013. The KLIMOP-study is a cohort study of
older cancer patients in Belgium and the Netherlands [16].
Setting and subjects
The study population consisted of patients living in the
Netherlands or Belgium. Patients with cancer were re-
cruited through hospitals; older patients without a previ-
ous diagnosis of cancer were recruited through general
practitioners [16]. Inclusion criteria for older cancer pa-
tients were 70 years or older, with a ﬁrst diagnosis of pros-
tate, lung, gastrointestinal, or breast cancer. The two
control groups consisted of older patients (≥70 years)
who have never been diagnosed with cancer, and
middle-aged patients (50–69 years) diagnosed with one
of the aforementioned cancer types. For more information
on the KLIMOP-study, we refer to the study protocol [16].
Data collection
Data were collected within 3 months of cancer diagnoses
in older cancer patients and middle-aged cancer patients.
Data were acquired by means of a personal interview or
self-administered questionnaires.
Measures
Depression was measured with the 15-item Geriatric
Depression Scale (GDS-15), coping strategy with the
abbreviated version of the Utrecht Coping List (UCL),
and health locus of control with the Multidimensional
Health Locus of Control (MHLC) scale [11,17,18]. Fur-
thermore, sex, age, level of education (age at which full-
time education was ﬁnished), marital status, and living sit-
uation were assessed.
The GDS-15 is a scale for depression consisting of 15
yes–no questions [18]. This scale was validated in older
primary care patients and in cancer patients treated with
palliative intention [19,20]. All items are summed up to
a total sum score, and a cutoff value of ≥5 for depression
was used. Sensitivity and speciﬁcity of the GDS-15 were
67% and 73%, respectively, using a diagnostic interview
as the gold standard [21,22]. Cronbach’s alpha of the
GDS-15 is 0.8 [23]. For patients who had less than ﬁve
missing items on the GDS-15, the missing items were im-
puted if this would not change categorization. Because
this study focuses on older cancer patients, we chose to
apply a geriatric scale, which also may be used in younger
patients, although it is known that presentation of depres-
sion differs from the younger population [24–26].
The short UCL covers four subscales: avoidance and
awaiting (three questions), active coping (ﬁve questions),
palliative reaction pattern (two questions), and seeking so-
cial support (ﬁve questions). Each question was answered
on a four-point Likert scale. For each subscale, sum scores
were divided by the number of questions, in order to pres-
ent each subscale on a range from 1 to 4 [17,27]. A higher
score indicates that a certain coping strategy is used more
often. The internal consistencies (Cronbach’s alpha) of the
UCL were 0.64 (avoiding), 0.84 (active), 0.44 (palliative),
and 0.82 (seeking social support) [28]. The UCL was val-
idated in people aged 14 years and older [17].
The MHLC consists of three subscales: the internal
scale, the external scale (also called ‘powerful others’),
and the ‘chance’ scale. Each subscale consists of three
items on a ﬁve-point Likert scale. Sum scores are divided
by the number of questions, in order to present each sub-
scale on a range from 1 to 5. Higher scores represent more
tendencies toward use of a certain locus of control [29].
Use of MHCL in older cancer patients has not been vali-
dated speciﬁcally, and validity of the MHLC is strongly
dependent from the context in which it is used [30]. In a
Dutch population, internal consistencies of the internal,
external, and chance locus are reported to be 0.74, 0.81,
and 0.67, respectively [28].
Statistical analysis
All statistical analyses were carried out using SPSS 21.
Sociodemographic and clinical characteristics of the study
population are presented as means and standard deviations
for continuous variables and as numbers and proportions
for categorical variables. Chi-square tests were used to
compare categorical variables between the different
J. W. F. Aarts et al.
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patient groups; t-tests for independent samples were used
to compare continuous variables.
The relationship between different variables and depres-
sion as the dependent variable was examined by means of
logistic regression; odds ratios (OR) and corresponding
95% conﬁdence intervals (CI) were calculated. Mean of
sum scores of the four UCL categories and mean of sum
scores of the MHLC subscales were used as independent
variables. Sex and age were used as confounders. We built
three models. In model 1, we only analyzed bivariate rela-
tions. In model 2, we adjusted for sex and age. In model 3,
we adjusted for all variables, using the backward condi-
tional method for logistic regression. In this method, the
remove limit was set at α<0.10 and the enter limit at
α<0.05. For all other analyses, a signiﬁcance level of
α<0.05 was used.
We tested for interactions between sex and the different
UCL and MHLC subscales, age and the different UCL
and MHLC subscales, presence of cancer and the different
UCL and MHLC subscales, and level of education and the
different UCL and MHLC subscales, by starting with a
full model (all variables and the aforementioned interac-
tions) and subsequently excluding the interaction term
with the highest p-value, until the highest p-value was less
than 0.05. Individual variables were excluded only if all
the interactions containing this variable were already ex-
cluded. In order to interpret signiﬁcant interactions, we
stratiﬁed the results for sex, cancer, and level of education
(≤14 years, 15–18 years and ≥19 years).
All our models showed a good ﬁt with the data accord-
ing to the Hosmer–Lemeshow’s test, with a signiﬁcance
level of 0.10.
Ethics and informed consent
The study protocol was approved by the ethical review
board of KU Leuven and UZ Leuven (S52097–ML6279)
(Belgium) and by the ethical review board of the Maas-
tricht University Medical Centre (NL.31414.068.10) (the
Netherlands). All patients signed informed consent.
Results
Population characteristics
Full data were available for 1317 participants. Of these,
332 were older cancer patients, 452 were older patients
without cancer and 533 were middle-aged cancer patients.
In one hospital, data collection was integrated in a routine
geriatric assessment; therefore, UCL and MHLC were not
available for 71 older cancer patients.
As shown in Table 1, there were more female patients in
all patient groups. The group of older cancer patients
consisted of 76 (27%) men and 206 (73%) women. The
mean age of the older cancer patients was 77.2 years (stan-
dard deviation (SD)=5.3).
Seventy-six patients had missing items for the GDS-15,
189 for the UCL and 153 for the MHLC. These patients
were excluded in multiple logistic regression analysis.
Hence, in the interaction analysis, 962 patients (73%)
were analyzed. Among the older cancer patients, there
were signiﬁcantly more patients excluded from logistic re-
gression analyses because of missing values (80 older can-
cer patients with missing values, 31%), compared with the
control groups (113 middle-aged cancer patients, 21%,
p<0.01 and 91 older patients without cancer, 20%,
p<0.01).
Depression
The overall prevalence of depression was 12%. There
were no differences between the three patient groups
(Table 1).
Coping
The mean UCL scores are shown in Table 1. Older cancer
patients scored signiﬁcantly higher for the avoidance/
awaiting coping strategy (2.05) than middle-aged cancer
patients (1.94, p=0.04) and signiﬁcantly lower for the
active coping (2.70 and 2.88, respectively, p<0.001),
palliative reaction pattern (2.11 and 2.29, respectively,
p<0.001) and seeking social support strategies (2.08
and 2.26, respectively, p<0.001). Older patients without
cancer scored even higher for the avoidance/awaiting
strategy than the older cancer patients group (2.17,
p=0.02).
Health locus of control
Older cancer patients scored signiﬁcantly lower for the
‘chance’ locus (2.46 and 2.73, respectively, p<0.001)
and the internal locus (2.62 and 2.80, respectively,
p=0.004) than middle-aged cancer patients (Table 1).
Older cancer patients scored signiﬁcantly higher for in-
ternal locus compared with older patients without cancer
(2.62 and 2.49, respectively, p=0.02).
Relationship between depression and coping strategy
and health locus of control
Table 2 shows the relationship of coping strategy and
health locus of control with depression. An avoiding
coping strategy is associated with a higher risk of depres-
sion (OR=1.73; 95% CI=1.31–2.29), also after adjusting
using models 2 and 3. Active coping was associated with a
lower risk of depression (OR=0.60; 95% CI=0.43–0.83),
also after adjusting using models 2 and 3. Throughout all
three models, there was a positive relationship between
internal health locus of control and depression. After
adjusting for all variables, the OR was 1.76 (95%
CI=1.35–2.29).
Health locus of control, coping strategy and depression
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Table 2. Coping strategy, health locus of control, sex, and age and their relationship with depression, odds ratio (95% CI)
Model 1 Model 2 Model 3
Coping strategy (UCL)
Avoidance/awaiting 1.73 (1.31–2.29) 1.76 (1.32–2.35) 1.43 (1.05–1.95)
Active coping 0.60 (0.43–0.83) 0.59 (0.42–0.82) 0.67 (0.46–0.96)
Palliative reaction pattern 0.92 (0.71–1.20) 0.90 (0.69–1.17) —
Seeking social support 0.85 (0.63–1.14) 0.83 (0.61–1.12) —
Health locus of control (MHLC)
‘Chance’ locus 1.01 (0.78–1.30) 1.01 (0.78–1.31) —
External locus – ‘powerful others’ 0.74 (0.56–0.97) 0.73 (0.55–0.96) 0.77 (0.56–1.05)
Internal locus 1.65 (1.29–2.11) 1.65 (1.29–2.13) 1.76 (1.35–2.29)
Sex
Men (reference: women) 0.87 (0.60–1.25) — —
Age 1.00 (0.98–1.02) — —
UCL, Utrecht Coping List; MHLC, Multidimensional Health Locus of Control.
Results based on logistic regression analysis.
Bold values indicate signiﬁcant p-values.
Model 1: unadjusted.
Model 2: adjusted for sex and age.
Model 3: adjusted for all variables.
Table 1. Patient characteristics, n (%) and comparison of prevalence of depression between patient groups, presented as n (%), comparison
of sum scores for UCL and MHLC between patient groups, presented as mean (range)
Older, without cancer p-value Older, with cancer p-value Middle-aged, with cancer
Sex n = 452 n= 332 n = 533
Male 175 (38.7%) 0.002† 94 (28.3%) 0.86† 148 (27.8%)
Female 277 (61.3%) 238 (71.7%) 385 (72.2%)
Age mean in years (SD) n = 452 n= 331 n = 533
78.22 (5.63) 0.001‡ 76.86 (5.31) <0.001‡ 59.86 (5.39)
Country of origin n = 443 n= 255 n = 519
Belgium 329 (74.3%) 0.01† 168 (65.9%) <0.001† 329 (63.4%)
the Netherlands 103 (23.3%) 85 (33.3%) 164 (31.6%)
Other 11 (2.5%) 2 (0.8%) 26 (5.0%)
Level of education mean in years (SD) n = 442 n= 315 n = 513
17.1 (3.72) 0.25‡ 16.8 (3.33) <0.001‡ 18.6 (3.83)
Marital status n = 447 n= 323 n = 524
Married/living together 279 (62.4%) 0.44† 187 (57.9%) <0.001† 417 (79.6%)
Unmarried/widow/divorced 167 (37.4%) 135 (41.8%) 104 (19.8%)
Other 1 (0.2%) 1 (0.3%) 3 (0.6%)
Living situation n = 447 n= 322 n = 520
Alone 139 (31.1%) 0.03† 101 (31.4%) <0.001† 74 (14.2%)
Living together 294 (65.8%) 198 (61.5%) 438 (84.2%)
Other 14 (3.1%) 23 (7.1%) 8 (1.5%)
GDS-15
Depressed 52 (11.9%) 0.40† 42 (14.0%) 0.67† 64 (12.9%)
Not depressed 385 (88.1%) 258 (86.0%) 431 (87.1%)
UCL
Avoidance/awaiting 2.17 (1.0–4.0) 0.02‡ 2.05 (1.0–4.0) 0.04‡ 1.94 (1.0–4.0)
Active coping 2.69 (1.0–4.0) 0.84‡ 2.70 (1.2–4.0) <0.001‡ 2.88 (1.0–4.0)
Palliative reaction pattern 2.00 (1.0–4.0) 0.08‡ 2.11 (1.0–4.0) 0.001‡ 2.29 (1.0–4.0)
Seeking social support 2.09 (1.0–4.0) 0.92‡ 2.08 (1.0–3.6) 0.001‡ 2.26 (1.0–4.0)
MHLC
‘Chance’ locus 2.50 (1.0–4.0) 0.43‡ 2.46 (1.0–5.0) <0.001‡ 2.73 (1.0–5.0)
External locus – ‘powerful others’ 2.37 (1.0–5.0) 0.30‡ 2.31 (1.0–4.3) 0.08‡ 2.41 (1.0–4.67)
Internal locus 2.49 (1.0–4.7) 0.02‡ 2.62 (1.0–5.0) 0.004‡ 2.80 (1.0–5.0)
UCL, Utrecht Coping List; MHLC, Multidimensional Health Locus of Control; GDS-15, 15-item Geriatric Depression Scale; SD, standard deviation.
Number of patients may differ per variable. For exact number of missing patients for the main variables, we refer to the text. Bold values indicate signiﬁcant p-values.
†Chi-square test.
‡t-test for independent samples.
J. W. F. Aarts et al.
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Interaction analysis
The results of our logistic regression analysis for interac-
tions are presented in Table 3. We found signiﬁcant inter-
actions with sex, presence/absence of cancer, and level of
education, when analyzing all patients. In order to inter-
pret the direction of these interactions, the analysis was
stratiﬁed for these variables.
A social support coping strategy is signiﬁcantly associ-
ated with less depression in women (OR=0.60; 95%
CI=0.39–0.91) but not in men (OR=1.85; 95%
CI=0.92–3.72). There also seems to be an interaction
between an active coping strategy and level of education.
The most educated patients (≥19 years) had a signiﬁcantly
lower risk of depression (OR=0.41; 95% CI=0.18–0.96).
For the interactions with presence of cancer, the degree of
interaction was not that clear after stratiﬁcation.
A summary of our main results is presented in Figure 1.
Conclusions
Main ﬁndings
The overall prevalence of depression was 12%. Older
cancer patients used an avoiding coping strategy more fre-
quently, which was associated with a higher prevalence of
depression. They used an active coping strategy less often,
which was associated with a lower prevalence of depres-
sion, in particular among more educated patients.
There were no important differences between older
cancer patients and older patients without cancer, except
for the internal locus of control and the avoiding coping
strategy.
Especially in women using a seeking social support
coping strategy, we found an association with a lower
prevalence of depression. Overall, the internal health locus
of control is associated with more depression, and the
external locus seemed to be associated with a lower prev-
alence of depression.
Comparison with literature and discussion of ﬁndings
The prevalence of depression in cancer patients is esti-
mated between 17% and 21%, in our study, this was
slightly lower [3,31,32]. This may be a consequence of
selection bias, moderate sensitivity of the GDS-15, or
the fact that cancer patients had to be diagnosed within
the last 3 months while development of depression takes
longer.
The ﬁndings that the active coping strategy is used less
frequently in older cancer patients and is associated with a
lower risk of depression, that use of an avoiding strategy is
associated with a higher risk of depression and that older
cancer patients use the internal locus of control less often
are in line with previous research [7,9,33,34]. T
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An unexpected ﬁnding was the association between use
of an internal health locus of control and a higher risk of
depression [35].
Our interaction analysis showed that the relation be-
tween a seeking social support coping strategy and depres-
sion was moderated by sex. The positive effect of seeking
social support on the risk of depression in women in par-
ticular has been described and can be explained by both
innate and socialization hypotheses [36,37]. Women more
frequently express their emotions and seek for social sup-
port than men. A possible important innate difference is
the fact that women possess higher levels of oxytocin than
men, which upregulates the parasympathetic nervous sys-
tem, and thereby leads to a more ‘tend-and-befriend’ pat-
tern, involving seeking social support [38,39]. Next to
this innate hypothesis, socialization might explain the
male–female difference, as people provide more social
support to women than men; it is easier for women to seek
for support [39].
The most important differences in health locus of control
and coping style appear to depend on age and not on being
diagnosed with cancer. Differences in external factors be-
tween the older and younger patient groups are importance
of religion, changing society, and being used to a more
paternal role of government and physicians. There could
also be an effect of aging itself.
Strengths and limitations
This study is one of the ﬁrst that speciﬁcally examined the
relation between health locus of control, coping strategy
and the risk of depression among older cancer patients,
with different types of cancer. Two control groups were
used; therefore, we could discriminate the effect of age
and the effect of being recently diagnosed with cancer.
Important limitations of our study are the cross-sectional
design and insufﬁcient power of our interaction after strat-
iﬁcation. The MHLC has not been validated in older can-
cer patients, and there were relatively many missing items
for UCL, MHLC and GDS-15.
Follow-up of patients from the KLIMOP-study is on-
going, and we expect to present longitudinal data within
a few years. It is interesting to evaluate if the results
within this cohort change when assessed later after cancer
diagnosis. The amount of patients in the KLIMOP-study
is still increasing, so in the future, the power for subgroup
analyses will also increase. We do not have speciﬁc infor-
mation regarding the participation rate of this study;
Figure 1. Summary ﬁgure of the main results. Only interactions considered relevant are presented. UCL, Utrecht Coping List; MHLC, Mul-
tidimensional Health Locus of Control; OR, odds ratio
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therefore, prudence is called for the generalization of
results.
Consequences
Although many studies have studied the concept of cop-
ing, there remains a relative absence of psychosocial inter-
ventions. Some studies, however, show promising results
regarding coping interventions. Effective interventions
teach patients how to use knowledge about coping styles
in daily practice and improve their functioning. Almost
all studied interventions are using a cognitive–behavioral
approach.
In clinical practice, healthcare workers should be aware
of the fact that older cancer patients differ from middle-
aged cancer patients.
Future research
Future research should focus on the change of coping strat-
egies and health locus of control especially in older cancer
patients, using a longitudinal study design. Additionally,
we still have to learn if screening for particular coping
strategies and use of a particular health locus of control
in the elderly will be effective and to what extent we can
inﬂuence the coping strategy or locus of control of the
older cancer patient and prevent depression.
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